Generic drug
Alogliptin / metformin price, strengths & recalls
Generic of Kazano
Pharmacies pay $73.40 for 30 tablets of Alogliptin / metformin 12.5 mg / 1000 mg tablet this week, and from $69.96 to $73.40 across its 2 priced strengths and forms. 2 manufacturers make it. Its official label last changed on August 26, 2026.
Generic- Fair cash price
- $94.91
- Strengths
- 2
- Makers
- 2
- Updated
- Nov 11
Alogliptin / metformin price by strength
What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.
| Strength and form | Per unit | Pharmacies pay |
|---|---|---|
| 12.5 mg / 1000 mg tablet | $2.45 | $73.40 / 30 tablets |
| 12.5 mg / 500 mg tablet | $2.33 | $69.96 / 30 tablets |
Brand names of alogliptin / metformin
A brand and its generic share the active ingredient; the generic is almost always far cheaper.
Supply status: shortages & recalls
What people paid for Alogliptin / metformin
Bought it recently? Share the price, the pharmacy and how you paid - it's the most useful thing the next person can read.
Official label & what changed
These highlights do not include all the information needed to use ALOGLIPTIN AND METFORMIN HCl TABLETS safely and effectively. See full prescribing information for ALOGLIPTIN AND METFORMIN HCl TABLETS. Alogliptin and Metformin Hydrochloride Tablets, for oral use Initial U.S. Approval: 2013
WARNING: LACTIC ACIDOSIS
Postmarketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension, and resistant bradyarrhythmia's. The onset of metformin-associated lactic acidosis is often subtle, accompanied only by nonspecific symptoms such as malaise, myalgias, respiratory distress, somnolence, and abdominal pain. Metformin-associated lactic acidosis was characterized by elevated blood lactate levels (greater than 5 mmol/L), anion gap acidosis (without evidence of ketonuria or ketonemia), an increased lactate/pyruvate ratio; and metformin plasma levels generally greater than 5 mcg/mL [see Warnings and Precautions (5.1)].
Risk factors for metformin-associated lactic acidosis include renal impairment, concomitant use of certain drugs (e.g., carbonic anhydrase inhibitors such as topiramate), age 65 years old or greater, having a radiological study with contrast, surgery and other procedures, hypoxic states (e.g., acute congestive heart failure), excessive alcohol intake, hepatic impairment and mitochondrial diseases [see Warnings and Precautions (5.1)].
Steps to reduce the risk of and manage metformin-associated lactic acidosis in these high risk groups are provided in the Full Prescribing Information [see Dosage and Administration (2.2), Contraindications (4), Warnings and Precautions (5.1), Drug Interactions (7), Use in Specific Populations (8.6, 8.7)].
If metformin-associated lactic acidosis is suspected, immediately discontinue alogliptin and metformin HCl tablets and institute general supportive measures in a hospital setting. Prompt hemodialysis is recommended [see Warnings and Precautions (5.1)].
WARNING: LACTIC ACIDOSIS
See full prescribing information for complete boxed warning.
Postmarketing cases of metformin-associated lactic acidosis have resulted in death, hypothermia, hypotension, and resistant bradyarrhythmia's. Symptoms included malaise, myalgias, respiratory distress, somnolence, and abdominal pain. Laboratory abnormalities included elevated blood lactate levels, anion gap acidosis, increased lactate/pyruvate ratio; and metformin plasma levels generally greater than 5 mcg/mL. (5.1)
Risk factors include renal impairment, concomitant use of certain drugs, age ≥65 years old, radiological studies with contrast, surgery and other procedures, hypoxic states, excessive alcohol intake, hepatic impairment, and mitochondrial diseases. Steps to reduce the risk of and manage metformin-associated lactic acidosis in these high risk groups are provided in the Full Prescribing Information. (5.1)
If lactic acidosis is suspected, discontinue alogliptin and metformin HCl tablets and institute general supportive measures in a hospital setting. Prompt hemodialysis is recommended. (5.1)
Recent major changes (as listed on the label)
RECENT MAJOR CHANGES
Boxed Warning...........................................................................08/2026
Warnings and Precautions, Lactic Acidosis (5.1)..............................08/2026
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Approval, patents & generics
- Application
- NDA203414 · Takeda Pharms USA
- First approved
- January 25, 2013 (13 years ago)
- Latest approved change
- August 11, 2026
- Approved label
- PDF, Aug 18, 2026
- Generic makers
- None on the market
- Last patent listed
- May 24, 2029
- Exclusivity ends
- July 27, 2026 (ended)
Alogliptin / metformin questions
How much does alogliptin / metformin cost without insurance?
Pharmacies pay about $73.40 for 30 tablets of alogliptin / metformin 12.5 mg / 1000 mg tablet ($2.45 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $94.91. If you're quoted much more, check your quote and ask for the pharmacy's cash price.
What is the brand name of alogliptin / metformin?
Alogliptin / metformin is sold as Kazano. The generic has the same active ingredient and usually costs far less.
Is alogliptin / metformin in shortage?
No shortage is reported for alogliptin / metformin right now. We check the national shortage list every day.
Has alogliptin / metformin been recalled?
No recalls are on record for alogliptin / metformin.
When did the alogliptin / metformin label last change?
The official label was last updated on August 26, 2026 (version 19). See what changed.
Talk about alogliptin / metformin
No comments yet. Questions, tips, what worked for you - start the conversation.